1437 Analysis by Treatment Period and Liver Function in EMERALD-1: a Phase 3 Study of Durvalumab ± Bevacizumab + TACE in Participants with Embolization-Eligible Unresectable Hepatocellular Carcinoma Stephen L Chan , Masatoshi Kudo , Thomas Decaens , Joseph P Erinjeri , Shukui Qin , Zhenggang Ren , Yasuaki Arai , Mohamed Bouattour , Valeriy V Breder , Shi-Ming Lin , Jeong Heo , Jean-Marie Peron , Vincenzo Mazzaferro , Quang T Nguyen , Joong-Won Park , Lunan Yan , Alejandro Molina Alavez , Chang-Fang Chiu , Kwong-Ming Kee , Florinda A Santos , Aibing Xu , Anil Veluvolu , Yoshitaka Inaba , Satheesh C Thungappa , Farshid Dayyani , David Hsieh , Vimal Dave , Claire Morgan , Kerry Parsons , Mallory Makowsky , Riccardo Lencioni , Bruno Sangro Regular and Young Investigator Award Abstracts（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
